New ASH guideline: VTE prophylaxis after major surgeryDecember 12, 2019DVT & Pulmonary EmbolismMixed Topics
Pulmonary embolism treatment teams adopted widely for complex diseaseNovember 20, 2019VEITHDVT & Pulmonary Embolism
Thromboembolic events more likely among CIDP patients with CVADOctober 29, 2019DVT & Pulmonary Embolism
FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patientsOctober 15, 2019DVT & Pulmonary Embolism
Occurrence of pulmonary embolisms in hospitalized patients nearly doubled during 2004-2015March 24, 2019DVT & Pulmonary Embolism
AUGUSTUS: Dual surpasses triple therapy when AFib patients have PCI or ACSMarch 19, 2019DVT & Pulmonary Embolism
ICYMI: Rivaroxaban reduces VTE incidence in ambulatory cancer patientsFebruary 20, 2019DVT & Pulmonary Embolism
Supplementary compression doesn’t improve DVT odds in critically illFebruary 20, 2019DVT & Pulmonary Embolism
ICYMI: Andexanet alfa reduces anti–factor Xa activity from apixaban, rivaroxabanFebruary 16, 2019DVT & Pulmonary EmbolismStroke
Venous thromboembolism risk elevated in ankylosing spondylitis patientsFebruary 12, 2019DVT & Pulmonary Embolism
Biomarkers predict VTE risk with menopausal oral hormone therapyFebruary 6, 2019DVT & Pulmonary Embolism
